The Effects of Streptomycin on Tuberculosis in Man , J. A. M. A. 135:634 (
(Nov. 8)
) 1947;.
Streptomycin in the Treatment of Tuberculosis: Current Status , J. A. M. A. 138:584 (
(Oct. 23)
) 1948;.
Current Status of the Chemotherapy of Tuberculosis in Man; A Summary Report , J. A. M. A. 142:650 (
(March 4)
) 1950;.
Hinshaw, H. C., and Feldman, W. H.: Streptomycin in Treatment of Clinical Tuberculosis: Preliminary Report , Proc. Staff Meet., Mayo Clin. 20:313, 1945;.
Minutes of the Eighth Streptomycin Conference, Nov. 10-13, 1949
Transactions of the Ninth Streptomycin Conference, April 18-21, 1950
Transactions of the Tenth Conference on the Chemotherapy of Tuberculosis , Jan. 25-28, 1951;, published by the Veterans Administration.
O'Connor, J. B.; Christie, F. J., and Howlett, K. S., Jr.: Neurotoxicity of Dihydrostreptomycin: Effects of Longer-Term Therapy , Am. Rev. Tuberc. 63:312, 1951;.
Canada, R. O.; Allison, S. T.; D'Esopo, N. D.; Dunner, E.; Moyer, R. E.; Shamaskin, A.; Tempel, C. W., and Charter, W. V.: Three-Year Follow-Up Study on 202 Cases of Pulmonary Tuberculosis Treated with Streptomycin , Am. Rev. Tuberc. 62:563, 1950;.
Bunn, P. A.: Two-Year Follow-Up Report of Patients with Miliary and Meningeal Tuberculosis Treated with Streptomycin , Am. J. M. Sc. 219:127, 1950;.
Lincoln, E. M., and Kirmse, T. W.: Streptomycin-Promizole Therapy of Miliary and Meningeal Tuberculosis in Children , Am. Rev. Tuberc. 61: 159, 1950;.
Walker, A. M.; Hinshaw, H. C., and Barnwell, J. B.: Streptomycin in Treatment of Tuberculosis in Man , in Waksman, S. A.: Streptomycin: Its Nature and Application , Baltimore, The Williams & Wilkins Company, 1949;, chap. 18.
Finlay, A. C., and others: Viomycin, a New Antibiotic Active Against Mycobacteria , Am. Rev. Tuberc. 63: 1, 1951;.
Bartz, O. R., and others: Viomycin, a New Tuberculostatic Antibiotic , Am. Rev. Tuberc. 63:4, 1951;.
Ehrlich, J., and others: Antimicrobial Activity of Streptomyces Floridae and of Viomycin , Am. Rev. Tuberc. 63:7, 1951;.
Hobby, G. L., and others: Activity of Viomycin Against Microorganisms in Vitro and in Vivo , Am. Rev. Tuberc. 63: 17, 1951;.
Youmans, G. P., and Youmans, A. S.: Effect of Viomycin in Vitro and in Vivo on Mycobacterium Tuberculosis , Am. Rev. Tuberc. 63:25, 1951;.
Steenken, W., Jr., and Wolinskey, E.: Viomycin in Experimental Tuberculosis , Am. Rev. Tuberc. 63:30, 1951;.
Karlson, A. G., and Gainer, J. H.: Effect of Viomycin in Tuberculosis of Guinea Pigs, Including in Vitro Effects Against Tubercle Bacilli Resistant to Certain Drugs , Am. Rev. Tuberc. 63:36, 1951;.
P'an, S. Y., and others: Viomycin: Acute and Chronic Toxicity in Experimental Animals , Am. Rev. Tuberc. 63:44, 1951;.
Werner, C. A., and others: Toxicity of Viomycin in Humans , Am. Rev. Tuberc. 63: 49, 1951;.
Hart, P. D., and Rees, R. J.: Enhancing Effect of Cortisone on Tuberculosis in the Mouse , Lancet 2:391, 1950;.
Spain, D. M., and Molomut, N.: Effects of Cortisone on the Development of Tuberculous Lesions in Guinea Pigs and on Their Modification by Streptomycin Therapy , Am. Rev. Tuberc. 62:337, 1950;.
Michael, M., Jr.; Cummings, M. M., and Bloom, W. L.: Course of Experimental Tuberculosis in the Rat as Influenced by Cortisone , Proc. Soc. Exper. Biol. & Med. 75:613, 1950;.
Nat. Tuberc. A. Tr. 37:4 (
(Jan.)
) 1951;.
Personal communications from Drs. William H. Feldman, Lawrence B. Hobson, and William Steenken Jr.